Skip to content
13 | 03 | 2023
—business

In the Press: Forbes

Alessandro Fier, Matteo Corbellino and Luca Trimigno nominated amongst Forbes' 30 Under 30' Class of 2023.

In an article published in November, Espansione Group's founder, Rodolfo Pomar, and Alessandro Fier, Chief Executive Officer, have been featured on Forbes in an article sharing few key highlights of the cross-generational exchange operation the two have brought forward. 

Quoting directly from the article:

To continue along this growth path, Alessandro Fier, Chief Executive Officer, shared that the company will continue to focus on research and development, as well as commercial excellence and partner support. "We are also carrying out an ambitious industrial plan," Fier tells us, "which will see major invest- ments in people and their skills, carrying out digitalization processes, development, and internal structuring to enhance the customer experience and our capabilities in terms of sales and marketing."

And, going further: 

Espansione’s projects also look beyond though. The medium-term goal is to become the gold standard technology in the treatment of dry eye and the ocular surface at a global level. The North American market will remain the main focus of the business plan for its reference function, although the entry into new markets such as China and Japan is expected in the coming months—key countries for positioning the company well on the global market, and a great way to make its technologies accessible worldwide.

Read the full article by downloading the .pdf below.
Access the original article on Forbes at this link [Language: Italian]

About Espansione Group

Espansione Group is a pioneer in the medtech industry, on a mission to develop and market innovative, non-invasive solutions for prevention and management of conditions in ophthalmology and beyond.  

The company’s certified medical solutions leverage proprietary technologies such as Light Modulation™ Low-level Light Therapy (LM™ LLLT) photobiomodulation (PBM), with an ambition to redefine standards of care by expanding on their applications, with a constant commitment to science, research and development, and customer excellence.

Strategic partnerships with the industry, a strong commitment to scientific excellence and a will to shape the future have enabled Espansione Group’s advanced medical technologies to be present in over 50 countries, serving thousands healthcare providers worldwide.

For more information, visit www.espansionegroup.it

 

Espansione Group Press Office
press@espansione.it 
© 2023 Espansione Group, All Rights Reserved
Posted on March 13th, 2023 in Newsroom

 

Get Started Now
Get in touch to find out how you can benefit from the Espansione Ecosystem of Technologies and Solutions.

In compliance with current regulations, let us know which audience you belong to:

You must fill in the form to download the file.

I want to be updated about Espansione products and services

This field is required.
This field is required.
This field is required.
A valid email address is required.
This field is required.
This field is required.
I have read the privacy policy and the terms and conditions of the site
This field is required.
I want to be updated about Espansione products and services. You can unsubscribe at any time, by using the “unsubscribe” feature at the bottom of any communication you receive.

Thank you for contacting us.